Cohance Lifesciences: A global CDMO platform with multi-modality expertise
One integrated platform across Small Molecule APIs, ADCs, and Nucleic Acid Chemistry—designed to simplify complexity and accelerate commercialization.
- Trusted by top pharma innovators around the world
- Leader in camptothecin-based payloads and intermediates
- Dedicated cGMP capabilities
- 1,000+ projects delivered with a proven track record
- 5 global manufacturing sites including USFDA & EDQM audited facilities
Talk to our CDMO experts
- One platform · Three modalities
Explore capabilities across the chemistries that matter the most
Switch between modalities to see how Cohance supports each from development through commercial manufacturing on a single accredited platform.
Small Molecule · HPAPI
Small Molecule APIs
Comprehensive capabilities to develop, scale, and manufacture complex small molecules with precision, safety, and regulatory confidence.
- KSMs, RSMs, intermediates & APIs across development stages
- Route scouting & process optimization (DoE) for yield, cost, and scalability
- Advanced analytical & safety studies (RC1, DSC, ARC)
- Complex, sensitive, and high-potency APIs
- Regulatory support for IND, IMPD, and DMF filings
- Scale-up & commercial manufacturing from grams to multi-ton
- Lifecycle support including impurity control and green processes
- Back-integrated supply chain
Comprehensive ADC & XDC Services
Comprehensive ADC & XDC Services
- Discovery support, tech transfer & scale-up across development stages
- Analytical development & regulatory documentation
- Phase-appropriate cGMP manufacturing
- Linker–payload optimization & bioconjugation expertise
- Broad conjugation chemistry experience with custom and standard linkers
- High-potency containment (OEB 6) with advanced safety controls
- Proprietary S-Trione payload platform with large-scale synthesis
- Commercial payload supply including Exatecan, Camptothecin, and MMAE
Nucleosides & Phosphoramidites Development and Manufacturing
Nucleosides & Phosphoramidites Development and Manufacturing
- Advanced capabilities for custom nucleic acid building blocks and scalable, cGMP-aligned manufacturing
- Custom nucleoside & amidite synthesis (proprietary and modified)
- Process development & scale-up from mg to multi-kg (cGMP & non-GMP)
- cGMP manufacturing for oligonucleotide building blocks
- Flexible engagement models (FTE or fixed scope)
- Late-stage development to batch production
- Regulatory-aligned manufacturing for global markets
- Inside Cohance
Learn More About Our Offerings
- Why partner with Cohance
Why Leading Innovators Choose Cohance
A trusted CDMO partner combining scientific depth, multi-modality expertise, and global scale to deliver complex programs with confidence.
Proven track record at scale
1,000+ projects delivered and 18 APIs successfully commercialized across global markets
True multi-modality expertise
Integrated capabilities across small molecule APIs, ADCs and bioconjugation, and nucleic acid chemistry
Global regulatory credibility
Manufacturing network audited by USFDA and EDQM, supporting worldwide submissions
Built for complex chemistry
Expertise in high-potency compounds, advanced payloads, and specialized nucleic acid building blocks
Flexible scale and delivery
From early development to commercial production with robust infrastructure and flexible engagement models
- Integrated processes
From Route Scouting to Commercial Supply
An integrated development and manufacturing platform that accelerates timelines, simplifies collaboration, and supports reliable scale up at every stage.
- 01
Route
Selection
- Route Selection Based on Any or All “SELECT” Criteria
- 02
Process
Development
- QbD (Quality by Design) Approach, CMA & CPP Identification
- Phase-Appropriate Process Development
- Process Engineering and Simulation
- Analytical Method Development, Validation, Impurity Identification, and Isolation
- 03
Technology
transfer
- Robust Technology Transfer Process
- Dedicated Support, Including Handholding for 2–3 Commercial Production Batches
- 04
Manufacturing and commercial supply
- Commercial Manufacturing at USFDA, EMA, and PMDA-Approved Sites
- Supported by Regulatory Expertise for IND, IMPD, and DMF Submissions Worldwide.
- 05
Product Lifecycle management
- Continuous Improvement and Cost Reduction Programs
- Reliable KSM Supply Chain Management, and Robust Business Continuity Planning (BCP) to Ensure Uninterrupted Supply.
- Start a conversation
Ready to discuss your next molecule?
Tell us about your program and a Cohance technical specialist will assess fit across modality, development phase, and manufacturing scale.
- Response within one business day
- Confidential, no-obligation conversation
- Speak directly with a technical specialist
Talk to our CDMO experts
Collaborate. Enhance. Deliver.
(Formerly, Suven Pharmaceuticals Limited)
- Terms Of Use
- Privacy Policy
- © 2026 Cohance Lifesciences Ltd. All rights reserved.